Journal ArticleOPEN ACCESS

Commentary: Chronic Lymphocytic Leukemia—The Price of Progress

  • Shanafelt T
  • Gunderson H
  • Call T
The Oncologist (2010) 15(6) 601-602
DOI: 10.1634/theoncologist.2010-0090
9Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The study looks at the high cost of new treatments for chronic lymphocytic leukemia and calls for the consideration of a standardized and transparent method to determine the price of new drugs based on comparative effectiveness.

Cite

CITATION STYLE

APA

Shanafelt, T. D., Gunderson, H., & Call, T. G. (2010). Commentary: Chronic Lymphocytic Leukemia—The Price of Progress. The Oncologist, 15(6), 601–602. https://doi.org/10.1634/theoncologist.2010-0090

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free